Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
11/2002
11/20/2002EP1257556A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002076990A8 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
11/14/2002CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/13/2002EP1256583A1 Pyrimidine-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
11/13/2002EP1255758A1 Apoptosis-inducing compounds
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002CN1379762A Beta substituted metalloprotease inhibitors
11/12/2002US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002CA2077102C Antibiotic ge 2270 factor c2a
11/07/2002US20020165202 Antiinflammatory agents; antiproliferative agents
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002CN1093767C Protein kinase C inhibitors
11/05/2002US6476059 Use of polycyclic 2-aminothiazole systems for the treatment of obesity
11/05/2002US6476021 Compounds having cGMP-PDE inhibitory effect
11/05/2002CA2037779C Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
11/04/2002WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002WO2002085915A2 Novel insecticidal azoles
10/31/2002WO2002085843A2 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002US20020161222 Hydrogenation of 5,5-dioxo-2,3-dihydro-1H-pyrrolo-(2,1-c)(1,2,4)benzothiadiazine with a complex of ruthenium dichloride with 2,2'-bis(diphenylphosphine)-1,1'-binaphthyl and 1,2-diphenylethylenediamine as catalyst
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/30/2002EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/29/2002US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/24/2002WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002WO2002066035A3 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002US20020156285 Novel herbicides
10/24/2002DE10119422A1 New fused bicyclic thiazoline or imidazoline derivatives, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
10/23/2002EP1251132A1 Synthesis of (3aS)-5,5-dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine
10/23/2002EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002EP1000067B1 Thiazolobenzoheterocycles, preparation and medicines containing same
10/22/2002US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002US6469017 Method of inhibiting interleukin-12 signaling
10/17/2002WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002US20020151713 Substituted 6,5-hetero-bicyclic derivatives
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002CN1374953A Aromatic nitrogenous six-membered ring compounds
10/10/2002WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002WO2002078695A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP0683774B1 Hypolipidaemic compounds
10/09/2002CN1092198C Z-mercapto-ethylamine cyclized hypocrellin and preparation process and use thereof
10/08/2002US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/03/2002WO2002076990A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
10/03/2002WO2002076954A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076463A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076375A2 Process for the preparation of benazepril
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
10/03/2002US20020141032 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices
10/03/2002CA2442573A1 Process for the preparation of benazepril
10/02/2002EP1246006A2 Dye-forming coupler, silver halide photographic light-sensitive material and azomethine dye compound
10/02/2002EP1245571A1 Benzbisazole compound and optical recording medium containing the compound
10/02/2002EP1100803B1 Pyrrolo [2,1-b] [1,3]benzothiazepines with atypical antipsychotic activity
10/02/2002EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
10/02/2002CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002US6458772 Prodrugs
10/01/2002US6458474 Methine compound, material for organic luminescence element, organic luminescence element using the same
09/2002
09/26/2002WO2000043375A3 Substituted aryl heterocyclic compounds
09/26/2002US20020137928 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/25/2002EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
09/25/2002EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002EP1242420A2 Agents and methods for the treatment of proliferative diseases
09/25/2002EP1242382A1 Tricyclic protein kinase inhibitors
09/25/2002EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
09/25/2002EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
09/25/2002CN1371374A Substituted heterocycle fused gamma-carbolines
09/24/2002US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
09/24/2002US6455523 Inhibitors of farnesyl protein transferase
09/19/2002WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
09/19/2002WO2002072562A1 Medicinal composition containing 1,3-thiazine derivative
09/19/2002WO2001016139A9 Androgen receptor modulator compounds and methods
09/19/2002US20020133022 Bactericides; grampositive bacteria
09/19/2002US20020132836 Compounds and methods for modulating CCR4 function
09/19/2002US20020132826 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
09/19/2002US20020132824 1,5-methylene-3-benzazepines used in treatment of neurological and psychological disorders,especially withdrawl from nicotine addiction
09/19/2002US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/19/2002US20020132765 Powerful activity when administered orally and by injection so that they can be used in a hospital environment via injection, followed by an oral ambulatory treatment
09/19/2002DE10112197A1 Medicaments for treating e.g. epilepsy, schizophrenia, neurodegenerative diseases or especially pain, comprising new or known pyrazolo-pyrimidine or thiazolo-pyrimidine compounds
09/18/2002EP0786462B1 DC107 derivatives
09/18/2002CN1370176A Subsstituted heterocycle fused gamma-carbolines
09/18/2002CN1370169A Substituted heterocycle fused gamma-carbolines
09/17/2002US6452013 For treating conditions which are related to impairment of gastric emptying
09/17/2002US6451843 Arylphenyl-substituted cyclic keto enols
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/12/2002WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 152